Weight Loss Drugs (BK2152) Stock Forum and Discussion

Weight Loss Drugs Watchlist

GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.

1498.369
-2.607-0.17%

Close Apr 28 16:00 ET

1505.856High1482.086Low

Constituent Stocks: 7Top Rising: VKTX+3.80%

105754083

12 hours ago

$Pfizer (PFE.US)$ what will the financial result gonna be today?

Moo Options Explorer

13 hours ago

Weekly roundup: Market shifts, tariff optimism, and earnings results

Hello mooers!
It’s been an eventful week in the markets, with a dramatic shift in sentiment from Monday’s bearish close to a four-day rally starting Tuesday. This change resulted from improving tariff dynamics and slightly better-than-expected earnings reports. As a result, $NASDAQ 100 Index (.NDX.US)$ surged 6.43% for the week, $S&P 500 Index (.SPX.US)$ rose 4.59%, and $Russell 2000 Index (.RUT.US)$ gained 4.09%, reflecting str...

+28

Teddy123

19 hours ago

Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer

$Pfizer (PFE.US)$
Breakthrough: Pfizer's New Bladder Cancer Treatment First Major Advance in 30 Years - See 91% Success Rate

Deep Sea

19 hours ago

$Pfizer (PFE.US)$
Pfizer (PFE) announced results from the pivotal Phase 3 CREST trial of sasanlimab, an investigational anti-PD-1 monoclonal antibody, in combination with standard of care Bacillus Calmette-Guerin as induction therapy with or without maintenance in patients with BCG-naive, high-risk non-muscle invasive bladder cancer, NMIBC. The trial met its primary endpoint of event-free survival, EFS, by investigator assessment, demonstrating a clinically meaningful and statistically significan...

搞经济抄底加仓

Apr 27 06:31

I'm just thinking if FDA, WHO, and them are together in this.. ? whatever cancer cure and other cure forever stop at 50% to 85% and they will change to another new treatment and then 50% to 85% and repeat.. seriously, is 2025 already they think we're still living in 1925 when all people don't go to school?
get done once, just once a 100%
$Johnson & Johnson (JNJ.US)$
$Pfizer (PFE.US)$
$E-mini NASDAQ 100 Futures(JUN5) (NQmain.US)$
$E-mini S&P 500 Futures(JUN5) (ESmain.US)$